Bradley Saenger
2018
In 2018, Bradley Saenger earned a total compensation of $616.2K as Chief Financial Officer at Tonix Pharmaceuticals Holding, a 69% increase compared to previous year.
Compensation breakdown
Bonus | $70,000 |
---|---|
Option Awards | $211,235 |
Salary | $335,000 |
Total | $616,235 |
Saenger received $335K in salary, accounting for 54% of the total pay in 2018.
Saenger also received $70K in bonus and $211.2K in option awards.
Rankings
In 2018, Bradley Saenger's compensation ranked 11,187th out of 14,244 executives tracked by ExecPay. In other words, Saenger earned more than 21.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,187 out of 14,244 | 22nd |
Division Manufacturing | 4,523 out of 5,765 | 22nd |
Major group Chemicals And Allied Products | 1,714 out of 2,128 | 20th |
Industry group Drugs | 1,454 out of 1,817 | 20th |
Industry Pharmaceutical Preparations | 1,115 out of 1,391 | 20th |
Source: SEC filing on December 13, 2019.
Saenger's colleagues
We found two more compensation records of executives who worked with Bradley Saenger at Tonix Pharmaceuticals Holding in 2018.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019